Search results
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 6 days agoMerck & Co- $30.5bn Merck & Co’s revenues reached $60.1bn in FY 2023, with R&D investments peaking at $30.5bn. Displaying a staggering 126% growth over...
Denali Therapeutics Q1 2024 Earnings: Misses Revenue Estimates Amid Strategic Shifts
GuruFocus.com via Yahoo Finance· 10 hours agoThis decline was primarily due to reduced revenues from partnerships with Sanofi and Takeda. Despite these challenges, Denali has managed to reduce its total research and ...
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters via Yahoo Finance· 6 days agoRegeneron's anti-inflammatory drug Dupixent brought in sales of $3.08 billion, as recorded by...
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant...
Benzinga· 6 days agoBeyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus (nirsevimab) substantially reduced RSV lower respiratory tract disease
Apiture Honored Among American Banker's Best Places to Work in Fintech 2024
Digital Journal· 17 hours agoAnnounces Quarterly Dividend...
GSK, Boehringer Put Profits Over User Safety, Zantac Jury Told
Insurance Journal· 2 days agoDrugmakers GSK Plc and Boehringer Ingelheim GmbH prioritized profits over consumer safety by hiding...
Cholera is making a comeback — and the world doesn’t have enough vaccines
Vox· 6 days agoAmid a global resurgence of cholera, the world is fighting with one hand tied behind its back. The...
3 Top French Dividend Stocks Offering Up To 6.5% Yield
Simply Wall St. via Yahoo Finance· 1 day agoAmid a backdrop of economic recovery and moderating inflation within the Eurozone, French markets...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 5 days agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron...